Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

CNS 4Sarcoma 1Lymphoid 1

Conditions

Breast Neoplasms 26Prostatic Neoplasms 24Brain Neoplasms 21Neoplasms 13Glioma 10Head and Neck Neoplasms 8Pancreatic Neoplasms 7Glioblastoma 6Lung Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 5Astrocytoma 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Lymphoma 4Central Nervous System Neoplasms 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Spinal Cord Neoplasms 3Sarcoma 3Liver Neoplasms 3Disease 3Retinoblastoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pathologic Complete Response 2Oligodendroglioma 2Neurofibromatosis 1 2Meningioma 2Lymphoma, Non-Hodgkin 2

Interventions

Temozolomide 64Radiotherapy 53Filgrastim 28Carboplatin 24Etoposide 20Irinotecan 17Vincristine 16Cyclophosphamide 16Cisplatin 15Carmustine 14Peripheral Blood Stem Cell Transplantation 13Magnetic Resonance Spectroscopy 12Bevacizumab 12Thiotepa 11Thalidomide 11Chemotherapy, Adjuvant 11Methotrexate 10Paclitaxel 9Granulocyte Colony-Stimulating Factor 9etoposide phosphate 8Surgical Procedures, Operative 8Procarbazine 8Ifosfamide 8sargramostim 7Topotecan 7O(6)-benzylguanine 7Lomustine 7Busulfan 7Radiation 6Melphalan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Central Nervous System Neoplasms × Magnetic Resonance Imaging × Clear all
NCT06381531 2025-04-11

TRACE

Tata Memorial Centre

Recruiting
10,000 enrolled
CNS

Brain Neoplasms, Neoplasms, Central Nervous System Neoplasms

NCT06036394 2025-04-09

AI-RAD

Tata Memorial Centre

Recruiting
6,000 enrolled
CNS

Brain Neoplasms, Glioma, Central Nervous System Neoplasms

NCT03188354 2024-01-05

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Norwegian University of Science and Technology

Phase NA Completed
3 enrolled
CNSLymphoid

Lymphoma, Non-Hodgkin, Central Nervous System Neoplasms

NCT00433472 2015-07-29

MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Withdrawn
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡